Holds 2 valid CEPs for calcipotriol, filing since 1993. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 17 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 2 valid CEPs for calcipotriol, filing since 1993. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 17 markets.
Holds 2 active US DMFs and 2 valid CEPs for calcipotriol, filing since 2006. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 valid CEPs for calcipotriol, filing since 2009. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for calcipotriol, filing since 2013. Its 2024 FDA inspection closed as VAI.
Registered with SFDA (Saudi Arabia) for calcipotriol. Its GMP is recognised in 7 markets.
Holds 2 active US DMFs for calcipotriol, filing since 2008.
Registered with SFDA (Saudi Arabia) for calcipotriol. Its 2025 FDA inspection closed as VAI.
Registered with SFDA (Saudi Arabia) for calcipotriol.
Registered with DAV (Vietnam) for calcipotriol. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for calcipotriol. Its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for freeFixed-dose combinations containing calcipotriol. Each page leads with the verified API makers of every component.